These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 7765176)
1. Protein engineering techniques for antibody humanization. Hurle MR; Gross M Curr Opin Biotechnol; 1994 Aug; 5(4):428-33. PubMed ID: 7765176 [TBL] [Abstract][Full Text] [Related]
2. Engineering antibodies for clinical applications. Jain M; Kamal N; Batra SK Trends Biotechnol; 2007 Jul; 25(7):307-16. PubMed ID: 17512622 [TBL] [Abstract][Full Text] [Related]
3. Antibodies as stratagems against cancer. Papageorgiou L; Cuong NT; Vlachakis D Mol Biosyst; 2016 Jun; 12(7):2047-55. PubMed ID: 26738941 [TBL] [Abstract][Full Text] [Related]
4. Leveraging SBDD in protein therapeutic development: antibody engineering. Gilliland GL; Luo J; Vafa O; Almagro JC Methods Mol Biol; 2012; 841():321-49. PubMed ID: 22222459 [TBL] [Abstract][Full Text] [Related]
5. [Progression and direction of humanized antibody research]. Lin Y; Yan XY Sheng Wu Gong Cheng Xue Bao; 2004 Jan; 20(1):1-5. PubMed ID: 16108479 [TBL] [Abstract][Full Text] [Related]
10. Humanization of a mouse anti-human IgE antibody: a potential therapeutic for IgE-mediated allergies. Kolbinger F; Saldanha J; Hardman N; Bendig MM Protein Eng; 1993 Nov; 6(8):971-80. PubMed ID: 8309946 [TBL] [Abstract][Full Text] [Related]
11. Intrabodies as drug discovery tools and therapeutics. Stocks M Curr Opin Chem Biol; 2005 Aug; 9(4):359-65. PubMed ID: 15979379 [TBL] [Abstract][Full Text] [Related]
12. Antibody Design and Humanization via In Silico Modeling. Kurella VB; Gali R Methods Mol Biol; 2018; 1827():3-14. PubMed ID: 30196489 [TBL] [Abstract][Full Text] [Related]
13. Humanization of a mouse monoclonal antibody by CDR-grafting: the importance of framework residues on loop conformation. Kettleborough CA; Saldanha J; Heath VJ; Morrison CJ; Bendig MM Protein Eng; 1991 Oct; 4(7):773-83. PubMed ID: 1798701 [TBL] [Abstract][Full Text] [Related]
14. Therapeutic advances in rheumatology with the use of recombinant proteins. Rothe A; Power BE; Hudson PJ Nat Clin Pract Rheumatol; 2008 Nov; 4(11):605-14. PubMed ID: 18813220 [TBL] [Abstract][Full Text] [Related]
15. Antibody engineering and therapeutics, The Annual Meeting of the Antibody Society: December 8-12, 2013, Huntington Beach, CA. Almagro JC; Gilliland GL; Breden F; Scott JK; Sok D; Pauthner M; Reichert JM; Helguera G; Andrabi R; Mabry R; Bléry M; Voss JE; Laurén J; Abuqayyas L; Barghorn S; Ben-Jacob E; Crowe JE; Huston JS; Johnston SA; Krauland E; Lund-Johansen F; Marasco WA; Parren PW; Xu KY MAbs; 2014; 6(3):577-618. PubMed ID: 24589717 [TBL] [Abstract][Full Text] [Related]
16. Humanization of predicted T-cell epitopes reduces the immunogenicity of chimeric antibodies: new evidence supporting a simple method. Roque-Navarro L; Mateo C; Lombardero J; Mustelier G; Fernández A; Sosa K; Morrison SL; Pérez R Hybrid Hybridomics; 2003 Aug; 22(4):245-57. PubMed ID: 14511570 [TBL] [Abstract][Full Text] [Related]
18. Antibody therapeutics, antibody engineering, and the merits of protein stability. Demarest SJ; Glaser SM Curr Opin Drug Discov Devel; 2008 Sep; 11(5):675-87. PubMed ID: 18729019 [TBL] [Abstract][Full Text] [Related]
19. Humanization and Simultaneous Optimization of Monoclonal Antibody. Kuramochi T; Igawa T; Tsunoda H; Hattori K Methods Mol Biol; 2019; 1904():213-230. PubMed ID: 30539472 [TBL] [Abstract][Full Text] [Related]